WallStreetZenWallStreetZen

NASDAQ: ACTU
Actuate Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Actuate Therapeutics earnings were -$25.3M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest ACTU earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$6.3M, down 2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ACTU reported annual earnings of -$27.3M, with 10.3% growth.

ACTU earnings history

Current Revenue
$0.0
Current Earnings
-$25.3M
Current Profit Margin
0%

ACTU Return on Equity

Insufficient data to display

ACTU undefined

Current Company
-339.7%
Current Industry
-2.5%
ACTU is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ACTU announces earnings.

ACTU undefined

Current Company
541.38%
Current Industry
5.8%

ACTU vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ACTU-$25.29M-$25.31MN/A-$3.85
ENGN-$76.07M-$79.88MN/A-$1.65
ALMS-$339.80M-$343.35MN/A-$26.88
ELDN-$37.94M-$38.71MN/A-$0.97
CYBN-$71.77M-$72.16MN/A-$3.41
View Top Biotech Stocks

Actuate Therapeutics Earnings Reports & History FAQ

What were Actuate Therapeutics's earnings last quarter?

Actuate Therapeutics (NASDAQ: ACTU) reported Q1 2025 earnings per share (EPS) of -$0.32, up 94.07% year over year. Total ACTU earnings for the quarter were -$6.32 million. In the same quarter last year, Actuate Therapeutics's earnings per share (EPS) was -$5.40.

If you're new to stock investing, here's how to buy Actuate Therapeutics stock.

Is Actuate Therapeutics profitable or losing money?

As of the last Actuate Therapeutics earnings report, Actuate Therapeutics is currently losing money. Actuate Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$25.31 million, a 8.87% decrease year over year.

What was ACTU's earnings growth in the past year?

As of Actuate Therapeutics's earnings date in Q2 2025, Actuate Therapeutics's earnings has grown year over year. ACTU earnings in the past year totalled -$25.31 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.